PQ 789
789. Deputy Michael Healy-Rae asked the Minister for Health the reason in most cases only limited information on the adverse drug reactions is provided to the Health Products Regulatory Authority in association with roaccutane since 1983; the other essential information concerning roaccutane that is withheld; by whom and the reason it is withheld; if he will provide details of same; and if he will make a statement on the matter. [30696/15]
Introduced
22 September 2015
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
22 September 2015
Summary
789. Deputy Michael Healy-Rae asked the Minister for Health the reason in most cases only limited information on the adverse drug reactions is provided to the Health Products Regulatory Authority in association with roaccutane since 1983; the other essential information concerning roaccutane that is withheld; by whom and the reason it is withheld; if he will provide details of same; and if he will make a statement on the matter. [30696/15]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medical Products
Medical Products
xml · EN · 22 September 2015
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2015-09-22/789/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2015-09-22/pq_789